Pfizer and BioNTech COVID vaccine 73.2% effective in children under 5, according to new data
Published
Pfizer Inc and BioNTech's COVID vaccine was approved for use in children under 5 years old in June, and new studies have shown the vaccine to be 73.2% effective within that age group.
Full Article